Back to Search
Start Over
Prevention of hearing loss in patients with multidrug-resistant tuberculosis
- Source :
- The Lancet. 390:934
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- In their Lancet Review, Blake S Wilson and colleagues (July 10)1 describe the growing global burden of hearing loss caused by a range of possible factors. The use of ototoxic medication is a considerable contributor to hearing loss for both children and adults. The authors suggest a primary prevention strategy for reducing hearing loss, which includes the use of ototoxic drugs only when no alternatives are available and only for serious conditions.
- Subjects :
- medicine.medical_specialty
Tuberculosis
Hearing loss
business.industry
030503 health policy & services
MEDLINE
Retrospective cohort study
11 Medical And Health Sciences
General Medicine
Audiology
medicine.disease
Multiple drug resistance
03 medical and health sciences
0302 clinical medicine
030228 respiratory system
General & Internal Medicine
Internal medicine
otorhinolaryngologic diseases
medicine
In patient
medicine.symptom
0305 other medical science
business
Subjects
Details
- ISSN :
- 01406736
- Volume :
- 390
- Database :
- OpenAIRE
- Journal :
- The Lancet
- Accession number :
- edsair.doi.dedup.....c4583c09702cb0c2151d02daedfe5f94
- Full Text :
- https://doi.org/10.1016/s0140-6736(17)32170-0